NMRA — NEUMORA THERAPEUTICS INC.
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 118 家机构在其最新 13F 申报中持有 NMRA(NEUMORA THERAPEUTICS INC.),合计申报市值 $139.89M,对应 82.12M 股。按股数计算较上季度增持 9.9%(+6.49M 股),申报市值环比下降 3.8%。持仓集中度较高:前五大持有人占申报市值的 38.3%,前十大的集中度为 58.0%。
与上一季度相比,31 家新建仓位、38 家加仓、24 家减仓、29 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
NEUMORA THERAPEUTICS INC.(NMRA)的主要机构持有人包括 Capital International Investors、Hillhouse Capital (HHLR Advisors)、Artal Group S.A.,按 13F 申报市值在本页 278 家持有人中排名居前。
NMRA 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 83 | 59.89M | $35.90M | +9.8% |
| Q2 2026 | 118 | 82.12M | $139.89M | +9.9% |
| Q1 2026 | 116 | 75.40M | $147.03M | -2.6% |
| Q4 2025 | 105 | 69.41M | $124.24M | +16.9% |
| Q3 2025 | 95 | 56.87M | $103.49M | -6.1% |
| Q2 2025 | 98 | 61.20M | $44.92M | -13.2% |
| Q1 2025 | 116 | 70.38M | $70.35M | -4.3% |
| Q4 2024 | 145 | 80.83M | $855.60M | +5.1% |
表内 8 个季度中,机构持股合计减少 26%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+16.9%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.50M | $5.07M | 0.12% | 持有 | |
| 8.14M | $4.85M | 0.00% | 增持 | |
| 4.67M | $2.78M | 0.00% | 持有 | |
| 4.50M | $2.68M | 0.12% | 增持 | |
| 4.46M | $2.66M | 0.57% | 持有 | |
| 4.22M | $2.51M | 0.01% | 持有 | |
| 3.31M | $1.97M | 0.02% | 持有 | |
| 2.80M | $1.67M | 0.00% | 增持 | |
| 2.60M | $1.55M | 0.00% | 减持 | |
| 2.12M | $1.27M | 0.18% | 持有 | |
| 1.85M | $1.10M | 0.14% | 持有 | |
| 1.71M | $1.02M | 0.00% | 增持 | |
| 1.13M | $673.55K | 0.00% | 减持 | |
| 961.70K | $573.17K | 0.00% | 增持 | |
| 952.05K | $567.62K | 0.00% | 增持 | |
| 922.96K | $550.09K | 0.00% | 增持 | |
| 805.81K | $480.26K | 0.00% | 增持 | |
| 787.27K | $469.37K | 0.36% | 增持 | |
| 655.85K | $391.01K | 0.00% | 减持 | |
| 618.36K | $368.67K | 0.01% | 减持 | |
| 557.33K | $332.95K | 0.00% | 减持 | |
| 163.39K | $277.76K | 0.15% | 持有 | |
| 404.33K | $241.06K | 0.00% | 新进 | |
| 330.51K | $198.31K | 0.00% | 减持 | |
| 247.54K | $147.59K | 0.00% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.43M | $11.51M | 0.07% | 减持 | |
| 6.29M | $11.26M | 0.34% | 增持 | |
| 4.54M | $8.13M | 0.00% | 增持 | |
| 4.46M | $7.98M | 1.81% | 持有 | |
| 4.22M | $7.55M | 0.03% | 持有 | |
| 3.67M | $6.58M | 0.03% | 新进 | |
| 3.62M | $6.47M | 0.00% | 增持 | |
| 3.62M | $6.47M | 0.01% | 增持 | |
| 3.50M | $6.26M | 0.00% | 持有 | |
| 3.31M | $5.92M | 0.06% | 持有 | |
| 2.56M | $4.58M | 0.07% | 持有 | |
| 2.12M | $3.80M | 1.44% | 持有 | |
| 2.02M | $3.62M | 0.00% | 增持 | |
| 1.85M | $3.31M | 0.60% | 持有 | |
| 1.45M | $2.59M | 0.00% | 增持 | |
| 1.31M | $2.34M | 0.01% | 增持 | |
| 1.28M | $2.29M | 0.27% | 增持 | |
| 1.08M | $1.94M | 0.00% | 增持 | |
| 1.00M | $1.80M | 0.00% | 增持 | |
| 967.24K | $1.73M | 0.09% | 减持 | |
| 858.50K | $1.54M | 0.00% | 增持 | |
| 638.78K | $1.14M | 0.03% | 持有 | |
| 583.76K | $1.04M | 0.00% | 新进 | |
| 572.50K | $1.02M | 0.01% | 增持 | |
| 534.04K | $956.00K | 0.08% | 增持 |
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.54M | $4.80M | 0.02% | 持有 | |
| 4.76M | $3.49M | 0.00% | 减持 | |
| 4.46M | $3.27M | 0.64% | 持有 | |
| 4.36M | $3.20M | 0.17% | 持有 | |
| 4.22M | $3.09M | 0.01% | 持有 | |
| 3.50M | $2.57M | 0.00% | 持有 | |
| 3.31M | $2.43M | 0.03% | 持有 | |
| 2.88M | $2.11M | 0.00% | 减持 | |
| 2.56M | $1.88M | 0.03% | 持有 | |
| 2.12M | $1.56M | 0.88% | 持有 | |
| 2.10M | $1.54M | 0.00% | 持有 | |
| 1.85M | $1.40M | 0.42% | 持有 | |
| 1.43M | $1.05M | 0.00% | 增持 | |
| 1.40M | $1.03M | 0.05% | 持有 | |
| 1.23M | $902.98K | 0.00% | 增持 | |
| 1.23M | $902.98K | 0.00% | 增持 | |
| 1.23M | $901.30K | 0.00% | 增持 | |
| 1.03M | $758.67K | 0.01% | 持有 | |
| 916.82K | $672.60K | 0.00% | 减持 | |
| 903.74K | $663.00K | 0.05% | 增持 | |
| 776.07K | $569.09K | 0.00% | 增持 | |
| 776.07K | $569.09K | 0.00% | 增持 | |
| 650.70K | $476.97K | 0.00% | 减持 | |
| 588.33K | $431.42K | 0.00% | 增持 | |
| 502.17K | $368.24K | 0.00% | 减持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.61M 股 · $4.43M
- ORBIMED ADVISORS LLC 2.14M 股 · $3.64M
- Boxer Capital Management, LLC 2.00M 股 · $3.40M
- Affinity Asset Advisors, LLC 1.07M 股 · $1.82M
- Sixth Street Partners Management Company, L.P. 823.58K 股 · $1.40M
- Ensign Peak Advisors, Inc 784.68K 股 · $1.33M
- Nuveen, LLC 136.66K 股 · $232.33K
- ALLIANCEBERNSTEIN L.P. 110.10K 股 · $214.69K
- Deutsche Bank AG 102.15K 股 · $173.65K
- Squadron Capital Management LLC 100.00K 股 · $170.00K
- PRICE T ROWE ASSOCIATES INC /MD/ 84.16K 股 · $144.00K
- Graham Capital Management, L.P. 47.92K 股 · $81.46K
完全清仓(较上季)
- PERCEPTIVE ADVISORS LLC 卖出 5.10M 股 · $9.95M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 卖出 1.00M 股 · $1.95M
- SILVERARC CAPITAL MANAGEMENT, LLC 卖出 818.16K 股 · $1.60M
- Point72 Asset Management 卖出 602.40K 股 · $1.17M
- Franklin Resources 卖出 511.08K 股 · $996.61K
- TANG CAPITAL MANAGEMENT LLC 卖出 439.88K 股 · $857.76K
- STATE STREET CORP 卖出 398.72K 股 · $777.50K
- HRT FINANCIAL LP 卖出 198.85K 股 · $387.00K
- ExodusPoint Capital Management, LP 卖出 191.68K 股 · $373.77K
- SkyOak Wealth, LLC 卖出 150.00K 股 · $292.50K
- EntryPoint Capital, LLC 卖出 110.88K 股 · $216.21K
- Brevan Howard Capital Management LP 卖出 97.08K 股 · $189.30K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siren, L.L.C. | 8.50M | 8.50M | 8.50M | 6.29M | 4.36M | 4.36M | 4.36M | 4.40M | 2.61M | — | — | — | — |
| BlackRock Inc | 8.14M | 7.79M | 2.05M | 2.02M | 1.82M | 2.88M | 6.35M | 7.11M | 6.19M | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.67M | 4.67M | 3.89M | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 4.50M | 1.07M | — | — | — | — | — | 475.00K | — | — | — | — | — |
| MIC Capital Management UK LLP | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M |
| Exor N.V. | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M |
| Geode Capital Management | 2.80M | 2.61M | 1.09M | 1.00M | 968.93K | 916.82K | 1.98M | 1.97M | 1.98M | 1.29M | 452.38K | 436.88K | 122.19K |
| Fidelity Management & Research (FMR) | 2.60M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 7.84M | 7.75M | 8.62M | 7.48M | 6.37M | 5.62M |
| Lunate Capital Ltd | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | — | — | — | — | — | — |
| JOHNSON & JOHNSON | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 912.13K |
| STATE STREET CORP | 1.71M | — | 398.72K | 388.92K | 388.92K | 351.25K | 1.72M | 2.06M | 1.79M | 1.08M | 259.18K | 141.48K | — |
| Renaissance Technologies | 1.13M | 1.26M | 1.39M | 1.45M | 1.16M | 1.43M | 1.26M | — | — | — | 138.90K | 13.60K | — |
| UBS Group AG | 961.70K | 143.72K | 59.58K | 94.91K | 129.05K | 650.70K | 3.11M | 12.00K | 339.67K | 295.66K | 25.28K | 256 | — |
| Qube Research & Technologies Ltd | 952.05K | 25.09K | 197.36K | — | — | — | — | — | — | — | 18.24K | — | 21.40K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 922.96K | 894.79K | 184.84K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 805.81K | 706.67K | 535.03K | — | — | — | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 787.27K | 500.00K | 100.00K | — | — | — | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 655.85K | 784.68K | — | — | — | — | — | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
| AlphaCore Capital LLC | 618.36K | 638.78K | 638.78K | 638.78K | 638.78K | 337.77K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold NMRA?
As of 2026-Q2, 118 institutional funds reported holding NMRA (NEUMORA THERAPEUTICS INC.) in SEC 13F filings, with a combined reported value of $139.89M.
How many shares of NMRA do institutions own?
13F filers reported 82.12M shares of NMRA, worth $139.89M in aggregate at the end of 2026-Q2.
Is institutional ownership of NMRA rising or falling?
Share counts moved +9.9% versus the prior quarter — accumulation.
Who are the top institutional holders of NMRA?
The largest 13F holders are Capital International Investors, Hillhouse Capital (HHLR Advisors), Artal Group S.A., EcoR1 Capital, LLC, Deep Track Capital, LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of NEUMORA THERAPEUTICS INC.?
The major shareholders of NEUMORA THERAPEUTICS INC. (NMRA) by reported 13F value are Capital International Investors, Hillhouse Capital (HHLR Advisors), Artal Group S.A., EcoR1 Capital, LLC, Deep Track Capital, LP, among 278 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.